Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04619875 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects
A NA study, sponsored by Kaleido Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04619875 is a NA study that has completed, run by Kaleido Biosciences. The registered enrollment target is 36 participants.
The verdict
NCT04619875, a NA study, has completed, sponsored by Kaleido Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This exploratory, randomized, open label study aims to explore the safety, tolerability, pharmacokinetics, and effects of increasing intake amounts of two novel glycans on the gut microbiota of healthy subjects.
Interventions
- OTHER KB5
- OTHER SG1
- OTHER Lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2017-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04619875
The ClinicalTrials.gov registry entry for NCT04619875 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaleido Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which KB5 is the first listed.
NCT04619875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04619875 about?
NCT04619875 is a clinical study titled "A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects". This exploratory, randomized, open label study aims to explore the safety, tolerability, pharmacokinetics, and effects of increasing intake amounts of two novel glycans on the gut microbiota of healthy subjects.
What is the current status of trial NCT04619875?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2017-09-11. Estimated completion is 2017-11-21.
What interventions are being tested in trial NCT04619875?
The interventions under investigation include: KB5 (OTHER), SG1 (OTHER), Lactulose (OTHER).
Who is sponsoring clinical trial NCT04619875?
This trial is sponsored by Kaleido Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.